GlaxoSmithKline (GSK) Pharmaceuticals, a global healthcare company, is going to pour Rs 1,000 crore in its new pharma unit in Karnataka. The company is also looking at enhancing its global pipeline in segments such as vac
The healthcare company is examining new possible products launches in the country from its global respiratory and vaccines pipeline and also reviewing complementary inorganic opportunities.
Almost 30% of the global pharmaceutical volumes sold by GSK is sold in the country.
The company is also upgrading its current Nashik facility. GSK India, in compliance with the GSK respiratory free strategy and the WHO requirement, has invested Rs 115 crore to construct a dedicated facility for the manufacturing of Eltroxin, which will be fully functional in 2018.
Stock view:
Glaxosmithkline Pharma Ltd is currently trading at Rs 2560, down by Rs 14.3 or 0.56% from its previous closing of Rs 2574.3 on the BSE.
The scrip opened at Rs 2565 and has touched a high and low of Rs 2599 and Rs 2500 respectively. So far 1476(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 21804.32 crore.
The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 3539.9 on 07-Jul-2016 and a 52 week low of Rs 2309.05 on 30-May-2017. Last one week high and low of the scrip stood at Rs 2600 and Rs 2490 respectively.
The promoters holding in the company stood at 75 % while Institutions and Non-Institutions held 12.18 % and 12.82 % respectively.
Every single information and details about market and stocks performance is very important and useful for all the traders and they should also know about the market working. To earn well on your investments you need to have great knowledge about trading strategies and current market status. To get more updates and investments ideas traders are taking intraday tips from the providers.
ReplyDeleteGlaxoSmithKline Pharmaceuticals Ltd. in its results for the first quarter ended June 2018 today posted a 235.31% year-on-year rise in net profit to Rs 88.59 crore for the quarter ended June from Rs 26.42 crore posted in the corresponding quarter last year.
ReplyDeleteStock Broker